Diana Borgas

Diana Borgas assists the Biotechnology Group in patent prosecution in the areas of molecular and cellular biology, genetics, biochemistry, and physiology. She has extensive knowledge in the areas of oncology, signal transduction, transgenic technology, mouse disease models, and mammalian tissue culture.

Recent Posts

Duck Salad: Don’t Let Claim Preambles Get Lost in the Weeds

Posted by Diana Borgas on Jun 12, 2017

Diana Borgas

Duck salad—not the tasty Asian dish, but rather a pesky aquatic weed that grows among rice crops—is the subject of the patent challenged in the recent IPR Aceto Agricultural Chemicals Corp. v. Gowan Company, LLC (IPR2016-00076). The Board’s final written decision illustrates a point that should not be overlooked: the broadest reasonable interpretation, which the Board applies to most claims in IPR, is not the broadest conceivable interpretation. The distinction made all the difference in this case. 

Read More

Topics: BioPharma

Wolf Greenfield's Post-Grant Blog

Here, the Post-Grant Proceedings Group
at Wolf Greenfield keeps you up to date
on the latest decisions and best practices, and what they mean for you. Learn more about the group and its members.

New Call-to-action
New Call-to-action
New Call-to-action

Subscribe to Email Updates

Recent Posts

Follow Us

This blog is intended to promote thought and debate on developing areas of the law. The opinions, commentary and characterizations of cases provided on this blog are not legal advice and do not represent the opinions of Wolf Greenfield or its clients.